secwatch.observer — SEC 8-K summary
======================================

Issuer:     Renalytix plc (RNLXY)
CIK:        0001811115
Form:       8-K
Filed at:   2023-07-03T23:59:59+00:00
Accession:  0000950170-23-031366
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Renalytix appoints Catherine Coste to Board of Directors as Audit Chair
-----------------------------------------------------------------------

- Catherine Coste, former Deloitte senior partner, appointed to board effective June 30, 2023.
- She will serve as Non-Executive Chair of Audit Committee and member of Remuneration Committee.
- Compensation: $40k/year director fee, plus $20k for Audit Chair, $7k for Remuneration Committee.
- Coste has 32 years finance experience, CPA, and serves on two other public company boards.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1811115/000095017023031366/0000950170-23-031366-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1811115/000095017023031366/rnlx-20230701.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-031366

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer